Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
The current price of STIM.BOATS is $1.45 USD — it has increased by +16% in the past 24 hours. Watch Neuronetics stock price performance more closely on the chart.
What is Neuronetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neuronetics stocks are traded under the ticker STIM.BOATS.
What is Neuronetics market cap?▼
Today Neuronetics has the market capitalization of 99.3M
When is the next Neuronetics earnings date?▼
Neuronetics is going to release the next earnings report on May 12, 2026.
What were Neuronetics earnings last quarter?▼
STIM.BOATS earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.11 USD resulting in a +5.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Neuronetics revenue for the last year?▼
Neuronetics revenue for the last year amounts to 149.78M USD.
What is Neuronetics net income for the last year?▼
STIM.BOATS net income for the last year is -87.42M USD.